Document is current
Any future updates will be listed below
-
Authors
Fernández Coves, Andrea
Scholte, Mirre
Wolff, Robert
Perry, Mark
Sugden, Bradley
Chen, Jiongyu
Armstrong, Nigel
Joore, Manuela
Witlox, Willem https://orcid.org/0000-0003-1007-4284
-
Funding
Funding for this research was provided by:
Health Technology Assessment Programme
- License Information
-
More Information
Article History
Received: 25 September 2025
Accepted: 5 October 2025
First Online: 16 February 2026
Declarations
:
: Andrea Fernández Coves, Mirre Scholte, Robert Wolff, Mark Perry, Bradley Sugden, Jiongyu Chen, Nigel Armstrong, Manuela Joore and Willem Witlox declare no conflicts of interest in relation to this work.
: The authors are part of the EAG that performed the independent review of the submission to NICE on fenfluramine hydrochloride for treating Lennox–Gastaut seizures in people aged 2 years and over. Therefore, all authors made substantial contributions to the conception and design of the work or the acquisition, analysis or interpretation of data for the work. AFC, WW and MS drafted the manuscript, and all other authors critically reviewed the work for important intellectual content. All authors read and approved the final version of this manuscript before submission and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
: Not applicable.
: Not applicable.
: Not applicable.
